July 13 (Reuters) –
* AVITA THERAPEUTICS- BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY TO INITIATE PROCUREMENT OF RECELL SYSTEM
* AVITA THERAPEUTICS- BARDA AGREED TO PURCHASE, STORAGE & DELIVERY OF RECELL SYSTEMS UNDER A VENDOR-MANAGED INVENTORY PLAN VALUED AT US$7.6 MILLION Source text for Eikon: Further company coverage: [ ]
Our Standards:The Thomson Reuters Trust Principles.
